Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00227877 · ClinicalTrials.gov registry record · NA
Screening and Brief Advice to Reduce Teen Substance Use
A NA study, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 2,695
- Enrollment target
NCT00227877: Completed NA study, sponsored by Boston Children's Hospital.
NCT00227877 is a NA study that has completed, run by Boston Children's Hospital. The registered enrollment target is 2,695 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00227877, a NA study, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,695 participants
- Enrollment target
Study Summary
The purpose of this study is to test the effectiveness of a brief intervention for alcohol and drug use in adolescents that a primary care doctor can give in his/her office. The study will be conducted in nine primary care offices in three New England states, and in ten pediatric offices in Prague, Czech Republic (CZR). We hypothesize that: 1. Among 12-18 year old well care patients who screen positive for drug/alcohol use, the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing drug and alcohol use; 2. Among 12-18 year old well care patients who screen negative for drug/alcohol use, the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing initiation of drug and alcohol use as measured by self-reports of substance use; 3. Among 12-18 year old well care patients who are at risk for riding with an impaired driver or driving while impaired, the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing Riding/Driving risk behavior as measured by a standardized scale.
Primary Outcome
Among the 12-18 year old primary care patients who reported past-12-month drug or alcohol use at baseline in New England, USA, this analysis reports the number who subsequently reported past-90-day drug or alcohol use at the 3 months post-baseline assessment.
Interventions
- BEHAVIORAL cSBA - New England, USA
- BEHAVIORAL cSBA - Prague, CZR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,695 participants |
| Start Date | 2005-12 |
| Est. Completion | 2010-02 |
| Phase | NA |
What the finished NCT00227877 record still lists
NCT00227877 is an interventional study that assigns participants to a tested intervention. Its 2,695 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% higher).
The record links to 0 conditions, and to 2 interventions - of which cSBA - New England, USA is the first listed.
NCT00227877 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00227877 about?
NCT00227877 is a clinical study titled "Screening and Brief Advice to Reduce Teen Substance Use". The purpose of this study is to test the effectiveness of a brief intervention for alcohol and drug use in adolescents that a primary care doctor can give in his/her office. The study will be conducted in nine primary care offices in three New England states, and in ten pediatric offices in Prague, ...
What is the current status of trial NCT00227877?
This trial is currently completed. It is a NA study. The enrollment target is 2,695 participants. The study started on 2005-12. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00227877?
The interventions under investigation include: cSBA - New England, USA (BEHAVIORAL), cSBA - Prague, CZR (BEHAVIORAL).
Who is sponsoring clinical trial NCT00227877?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00227877's enrollment target sits among peer trials
2,695 44th of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04073420 · 2,700 participants
Medtronic Cardiac Surgery PMCF Registry
- NCT05125939 · 2,700 participants
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
- NCT05586776 · 2,700 participants · Phase 4
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
- NCT06052267 · 2,700 participants · Phase 3
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia